Abstract

Stability of Pergolide Mesylate Oral Liquid at Room Temperature

Author(s): Shank Brandon R, Ofner Clyde M III

Issue: May/Jun 2009 - Pain Management

Page(s): 254-258

Download in electronic PDF format for $75
  • Stability of Pergolide Mesylate Oral Liquid at Room Temperature Page 1
  • Stability of Pergolide Mesylate Oral Liquid at Room Temperature Page 2
  • Stability of Pergolide Mesylate Oral Liquid at Room Temperature Page 3
  • Stability of Pergolide Mesylate Oral Liquid at Room Temperature Page 4
  • Stability of Pergolide Mesylate Oral Liquid at Room Temperature Page 5

Abstract

Pergolide mesylate (proprietary name Permax) is used to treat equine Cushing’s syndrome. Since pergolide mesylate has been removed from the market, the tablets are no longer available. Therefore, pergolide mesylate preparations have to be compounded for veterinary use. Compounded oral liquid formulations have been given arbitrary beyond-use dates of 14 days (aqueous) to 90 days (oil based). The goal of this study was to determine the stability of a 0.2 mg/mL pergolide oral liquid prepared according to a previously published formulation and stored at room temperature. The sample preparation and the high-performance liquid chromatographic assay described in the United States Pharmacopeia–National Formulary were modified to treat the oral liquid as a suspension. The assay was evaluated prior to its use. A linear relationship was found between peak area and concentration, with R2 values ranging from 0.989 to 0.999 for three of the sample calibration plots. The daily reproducibility and day-to-day variability of s

Related Keywords

  • pergolide mesylate
  • stability
  • storage temperature
  • equine Cushing syndrome
  • horses
  • formulation

Related Categories

  • FORMULATIONS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • VETERINARY
  • DOSAGE FORMS/DRUG CARRIERS
  • STORAGE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2009
Pg. 254-258
Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Author(s): Shank Brandon R, Ofner Clyde M III
Jan/Feb 2003
Pg. 27-29
Equine Cushing’s Syndrome
Author(s): Vail Jane
Jul/Aug 2019
Pg. 281-287
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Author(s): Newton David W
Sep/Oct 2018
Pg. 410
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 232
Pergolide 0.2-mg/mL Oral Liquid, Veterinary
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 231
Pergolide 500-mcg Capsules, Veterinary
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 428-431
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Author(s): Nahata Milap C
Mar/Apr 2004
Pg. 130-131
Calibration/Validation of Incubator Temperature
Author(s): Allen Loyd V Jr
Jan/Feb 2008
Pg. 83-85
Room Temperature Stability of Injectable Succinylcholine Dichloride
Author(s): Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
Sep/Oct 2007
Pg. 384-388
Equine Cushing's Disease: A Clinical Update
Author(s): Bliss George
May/Jun 2012
Pg. 258-261
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste
Author(s): Dudley Richard, McDowell Brean, Mahl Carissa, Sarkar Arindam Basu
Sep/Oct 2025
Pg. 439-446
Long-Term Physicochemical Stability of a Morphine-Ketamine Admixture in Polypropylene Syringes at Room Temperature
Author(s): Devis Luigi, Colsoul Marie-Lise, Bihin Benoît, Jamart Jacques, Soumoy Laura, Lombet Louise, Hecq Jean-Daniel, Galanti Laurence, Closset Mélanie, Catry Emilie
May/Jun 2003
Pg. 228-229
Standard Operating Procedure: Incubator Temperature Monitoring
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 268
PreScription: Temperatures by Degrees
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 251
Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2016
Pg. 41-45
Formulation and Stability of Solutions
Author(s): Akers Michael J
Nov/Dec 2016
Pg. 521-525
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Author(s): Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
Sep/Oct 2002
Pg. 388-390
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Author(s): Storms Meredith L, Stewart James T, Warren Flynn W
Jan/Feb 2000
Pg. 66-68
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Author(s): Gupta Vishnu D, Bailey RE
Jul/Aug 2002
Pg. 255-256
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Author(s): Mason Dave